7.85
1.03%
0.08
Handel nachbörslich:
7.85
Finanzdaten der Maravai Lifesciences Holdings Inc-Aktie (MRVI)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
13.44%
64.18
|
74.14 | 66.86 | 68.91 | 79.03 |
Cost Of Revenue |
9.19%
38.34
|
35.11 | 36.69 | 43.27 | 33.68 |
Gross Profit |
33.79%
25.84
|
39.03 | 30.18 | 25.64 | 45.35 |
Operating Expenses
|
3.20%
44.70
|
46.18 | 45.60 | 37.26 | 42.82 |
Interest Income/Expense |
29.45%
10.86
|
15.40 | 11.64 | 7.022 | 11.83 |
Benefits Costs and Expenses |
114.88%
86.59
|
-582.04 | 87.43 | 82.28 | 83.55 |
Costs And Expenses |
2.15%
83.04
|
81.29 | 82.28 | 80.53 | 76.49 |
Operating Income/Loss |
163.79%
-18.86
|
-7.15 | -15.42 | -11.61 | 2.533 |
Income/Loss From Continuing Operations Before Tax |
103.42%
-22.41
|
656.19 | -20.56 | -13.36 | -4.523 |
Income Tax Expense/Benefit, Deferred |
100.00%
-
|
764.75 | -5.532 | -2.756 | -1.52 |
Income Tax Expense/Benefit |
99.96%
0.271
|
766.17 | -5.461 | -1.421 | -3.175 |
Income/Loss From Continuing Operations After Tax |
79.38%
-22.68
|
-109.98 | -15.10 | -11.94 | -1.348 |
Net Income/Loss
|
79.38%
-22.68
|
-109.98 | -15.10 | -11.94 | -1.348 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
163.53%
-10.60
|
-4.023 | -8.64 | -5.402 | -1.281 |
Basic Average Shares |
178.73K%
132.33
|
0.074 | 131.93 | 131.86 | 131.74 |
Diluted Average Shares |
178.73K%
132.33
|
0.074 | 131.93 | 131.86 | 131.74 |
Basic Earnings Per Share |
88.75%
-0.09
|
-0.80 | -0.05 | -0.05 | - |
Diluted Earnings Per Share |
88.75%
-0.09
|
-0.80 | -0.05 | -0.05 | - |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):